These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Drug-induced lupus erythematosus. Vedove CD; Del Giglio M; Schena D; Girolomoni G Arch Dermatol Res; 2009 Jan; 301(1):99-105. PubMed ID: 18797892 [TBL] [Abstract][Full Text] [Related]
4. Drug-induced lupus: an update on its dermatologic aspects. Marzano AV; Vezzoli P; Crosti C Lupus; 2009 Oct; 18(11):935-40. PubMed ID: 19762393 [TBL] [Abstract][Full Text] [Related]
5. Drug-induced lupus erythematosus in childhood: Case-based review. Kaya Akca U; Sener S; Batu ED; Balik Z; Basaran O; Bilginer Y; Ozen S Lupus; 2024 Jun; 33(7):737-748. PubMed ID: 38580326 [TBL] [Abstract][Full Text] [Related]
6. Drug-induced lupus erythematosus. Pretel M; Marquès L; España A Actas Dermosifiliogr; 2014; 105(1):18-30. PubMed ID: 23164669 [TBL] [Abstract][Full Text] [Related]
7. The clinical application of an ELISA technique for the detection of antihistone antibodies. Epstein A; Greenberg M; Halbert S; Kramer L; Barland P J Rheumatol; 1986 Apr; 13(2):304-7. PubMed ID: 3522897 [TBL] [Abstract][Full Text] [Related]
8. The diagnostic value of antihistone antibodies in drug-induced lupus erythematosus. Epstein A; Barland P Arthritis Rheum; 1985 Feb; 28(2):158-62. PubMed ID: 3882094 [TBL] [Abstract][Full Text] [Related]
9. Pearls for the diagnosis and possible pathophysiological mechanisms of valproic acid-induced lupus erythematosus: A literature review. Papadopoulou E; Saroglou M; Ismailos G; Fletsios D; Tsavlis D; Tryfon S Lupus; 2022 May; 31(6):650-658. PubMed ID: 35324365 [No Abstract] [Full Text] [Related]
10. Drug-induced lupus erythematosus: an update on drugs and mechanisms. He Y; Sawalha AH Curr Opin Rheumatol; 2018 Sep; 30(5):490-497. PubMed ID: 29870500 [TBL] [Abstract][Full Text] [Related]
11. Cefuroxime-induced lupus. Uz E; Bavbek N; Turgut FH; Kanbay M; Kaya A; Akcay A J Natl Med Assoc; 2007 Sep; 99(9):1066-7. PubMed ID: 17913119 [TBL] [Abstract][Full Text] [Related]
13. [Acute disseminated lupus erythematosus. Responsibility of Corenitec: apropos of a case]. Rosenfeld N; Yeche S; Reynaud D; Abiad L; Dubois A Therapie; 1999; 54(4):493-4. PubMed ID: 10667119 [No Abstract] [Full Text] [Related]
14. Characterization of patients with infliximab-induced lupus erythematosus and outcomes after retreatment with a second anti-TNF agent. Subramanian S; Yajnik V; Sands BE; Cullen G; Korzenik JR Inflamm Bowel Dis; 2011 Jan; 17(1):99-104. PubMed ID: 20629183 [TBL] [Abstract][Full Text] [Related]
15. Clinical use of anti-histone antibodies in idiopathic and drug-induced lupus. Lee AYS Immunol Med; 2022 Dec; 45(4):180-185. PubMed ID: 35383534 [TBL] [Abstract][Full Text] [Related]